These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 1522168)

  • 21. Treatment of Helicobacter pylori infection.
    Ebell MH
    J Fam Pract; 1996 Jun; 42(6):568. PubMed ID: 8656165
    [No Abstract]   [Full Text] [Related]  

  • 22. Eradication rates of helicobacter pylori infection with second-line treatment: non-ulcer dyspepsia compared to peptic ulcer disease.
    Chung SJ; Lee DH; Kim N; Jung SH; Kim JW; Hwang JH; Park YS; Lee KH; Jung HC; Song IS
    Hepatogastroenterology; 2007 Jun; 54(76):1293-6. PubMed ID: 17629092
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clarithromycin, tetracycline, and bismuth: a new non-metronidazole therapy for Helicobacter pylori infection.
    al-Assi MT; Ramirez FC; Lew GM; Genta RM; Graham DY
    Am J Gastroenterol; 1994 Aug; 89(8):1203-5. PubMed ID: 8053435
    [TBL] [Abstract][Full Text] [Related]  

  • 24. H pylori in patients with peptic ulcer disease.
    Strickland C
    J Fam Pract; 1998 Feb; 46(2):117. PubMed ID: 9487314
    [No Abstract]   [Full Text] [Related]  

  • 25. [Eradication therapy for peptic ulcer disease in Helicobacter pylori positive patients].
    Søndergaard B; Bytzer P
    Ugeskr Laeger; 2005 Jan; 167(5):500-2. PubMed ID: 15745170
    [No Abstract]   [Full Text] [Related]  

  • 26. H. pylori and ulcers.
    McGuffey EC
    Am Pharm; 1994 Jul; NS34(7):21. PubMed ID: 8085532
    [No Abstract]   [Full Text] [Related]  

  • 27. Antimicrobial therapy for Helicobacter pylori infection versus long-term maintenance antisecretion treatment in the prevention of recurrent hemorrhage from peptic ulcer: prospective nonrandomized trial on 125 patients.
    Santander C; Grávalos RG; Gómez-Cedenilla A; Cantero J; Pajares JM
    Am J Gastroenterol; 1996 Aug; 91(8):1549-52. PubMed ID: 8759659
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Helicobacter pylori in peptic ulcer disease.
    Del Med J; 1994 Oct; 66(10):557-8. PubMed ID: 7958122
    [No Abstract]   [Full Text] [Related]  

  • 29. Helicobacter pylori eradication in peptic dyspepsia.
    Lule GN
    East Afr Med J; 2005 Dec; 82(12):601-2. PubMed ID: 16619702
    [No Abstract]   [Full Text] [Related]  

  • 30. [Eradication therapy of Helicobacter pylori--associated diseases: efficacy, safety, pharmacoeconomy].
    Grinevich VB; Sablin OA; Gubonina IV; Dobrenko VA
    Eksp Klin Gastroenterol; 2005; (2):95-9. PubMed ID: 15932163
    [No Abstract]   [Full Text] [Related]  

  • 31. [Treatment of Helicobacter pylori positive ulcer--the search for simple and effective therapy].
    Eliakim R; Rachmileweitz D
    Harefuah; 1996 Nov; 131(10):405-6. PubMed ID: 8981820
    [No Abstract]   [Full Text] [Related]  

  • 32. Eradication of helicobacter pylori among patients from a primary care practice.
    Gomollón F; Gimeno L; Valdepérez J; Yus C; Marzo J; Pérez-Caballero MC
    J Fam Pract; 1996 Dec; 43(6):551-5. PubMed ID: 8969702
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of peptic ulcer disease: is Helicobacter pylori a consideration?
    Pajares JM; Carballo F; Blanco M
    Hepatogastroenterology; 1992 Feb; 39 Suppl 1():40-4. PubMed ID: 1349551
    [No Abstract]   [Full Text] [Related]  

  • 34. [Current criteria for the treatment of peptic ulcer].
    Díaz-Rubio García DM
    An R Acad Nac Med (Madr); 1996; 113(1):213-21; discussion 221-5. PubMed ID: 8967574
    [No Abstract]   [Full Text] [Related]  

  • 35. Bismuth-based combination therapy for Helicobacter pylori-associated peptic ulcer disease (metronidazole for eradication, ranitidine for pain).
    Tefera S; Berstad A; Bang CJ; Nysaeter G; Hatlebakk JG; Olafsson S; Nesje LB; Hausken T; Berstad K; Hundal O
    Am J Gastroenterol; 1996 May; 91(5):935-41. PubMed ID: 8633584
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Comparison of the effectiveness of tri- and quadricomponent eradication therapy in patients with peptic ulcer].
    Butorov IV; Osoianu IuP; Butorov SI; Maksimov VV
    Klin Med (Mosk); 2005; 83(12):50-3. PubMed ID: 16502725
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Assessment of the efficacy of de-nol and bismuth subnitrate treatment of patients with associated peptic ulcer and pyloric Helicobacter infection (experimental and clinical studies)].
    Il'chenko AA; Zurabishvili NG; Zhukhovitskiĭ BG; Gorodinskaia VS
    Ter Arkh; 1991; 63(2):21-6. PubMed ID: 2048016
    [TBL] [Abstract][Full Text] [Related]  

  • 38. One-week ranitidine bismuth citrate versus colloidal bismuth subcitrate-based anti-Helicobacter triple therapy: a prospective randomized controlled trial.
    Kung NN; Sung JJ; Yuen NW; Li TH; Ng PW; Lai WM; Lui YH; Lam KN; Choi CH; Leung EM
    Am J Gastroenterol; 1999 Mar; 94(3):721-4. PubMed ID: 10086657
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cure of Helicobacter pylori: a hidden curse?
    Srinivasan R; Minocha A
    Am J Gastroenterol; 1997 Dec; 92(12):2313-4. PubMed ID: 9399784
    [No Abstract]   [Full Text] [Related]  

  • 40. [The drug prophylaxis of peptic ulcer exacerbations].
    Grigor'ev PIa; Iakovenko EP; Agafonova NA; Prianishnikova AS; Soluianova IP; Iakovenko AV; Vasil'ev IV; Agrba VZ; Stepanov AV; Kolodkin AM
    Ter Arkh; 1995; 67(2):26-9. PubMed ID: 7725253
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.